Medtronic Invests In Pi-Cardia To Accelerate Innovation For Complex Transcatheter Aortic Valve Replacement Patients And Procedures
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, and Pi-Cardia Ltd., a pioneer in leaflet modification technologies for structural heart disease, today announced a strategic investment
Medtronic, a big medical company, is putting money into a smaller company called Pi-Cardia to help them build better tools for fixing broken heart valves. When large companies invest in smaller ones, it usually means they believe in that technology and think it could help their business grow.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.